300 related articles for article (PubMed ID: 27826554)
1. Living donor liver transplantation for hepatocellular carcinoma at the University of Tokyo Hospital.
Togashi J; Akamastu N; Kokudo N
Hepatobiliary Surg Nutr; 2016 Oct; 5(5):399-407. PubMed ID: 27826554
[TBL] [Abstract][Full Text] [Related]
2. Impact of incidental/misdiagnosed intrahepatic cholangiocarcinoma and combined hepatocellular cholangiocarcinoma on the outcomes of liver transplantation: an institutional case series and literature review.
Gupta R; Togashi J; Akamatsu N; Sakamoto Y; Kokudo N
Surg Today; 2017 Aug; 47(8):908-917. PubMed ID: 28124125
[TBL] [Abstract][Full Text] [Related]
3. Predictor of outcome after living donor liver transplantation for patients with hepatocellular carcinoma beyond the Japan criteria.
Yonemura Y; Yoshizumi T; Inokuchi S; Kosai-Fujimoto Y; Harada N; Itoh S; Toshima T; Takeishi K; Yoshiya S; Mori M
Ann Gastroenterol Surg; 2020 Jul; 4(4):413-421. PubMed ID: 32724885
[TBL] [Abstract][Full Text] [Related]
4. Section 5. Further expanding the criteria for HCC in living donor liver transplantation: when not to transplant: SNUH experience.
Lee KW; Yi NJ; Suh KS
Transplantation; 2014 Apr; 97 Suppl 8():S20-3. PubMed ID: 24849825
[TBL] [Abstract][Full Text] [Related]
5. Prognostic impact of des-γ-carboxyl prothrombin in living-donor liver transplantation for recurrent hepatocellular carcinoma.
Harimoto N; Yoshida Y; Kurihara T; Takeishi K; Itoh S; Harada N; Tsujita E; Yamashita YI; Uchiyama H; Soejima Y; Ikegami T; Yoshizumi T; Kawanaka H; Ikeda T; Shirabe K; Saeki H; Oki E; Kimura Y; Maehara Y
Transplant Proc; 2015 Apr; 47(3):703-4. PubMed ID: 25819732
[TBL] [Abstract][Full Text] [Related]
6. Comparative evaluation of expanded criteria for patients with hepatocellular carcinoma beyond the Milan criteria undergoing living-related donor liver transplantation.
Shirabe K; Taketomi A; Morita K; Soejima Y; Uchiyama H; Kayashima H; Ninomiya M; Toshima T; Maehara Y
Clin Transplant; 2011; 25(5):E491-8. PubMed ID: 21518000
[TBL] [Abstract][Full Text] [Related]
7. Liver transplantation for combined hepatocellular carcinoma and cholangiocarcinoma: A multicenter study.
Kim J; Joo DJ; Hwang S; Lee JM; Ryu JH; Nah YW; Kim DS; Kim DJ; You YK; Yu HC
World J Gastrointest Surg; 2023 Jul; 15(7):1340-1353. PubMed ID: 37555110
[TBL] [Abstract][Full Text] [Related]
8. Extended indication for living donor liver transplantation in patients with hepatocellular carcinoma.
Soejima Y; Taketomi A; Yoshizumi T; Uchiyama H; Aishima S; Terashi T; Shimada M; Maehara Y
Transplantation; 2007 Apr; 83(7):893-9. PubMed ID: 17460559
[TBL] [Abstract][Full Text] [Related]
9. Living donor liver transplantation for combined hepatocellular-cholangiocarcinoma: A case series of four patients.
Ito T; Ishii T; Sumiyoshi S; Ogiso S; Fukumitsu K; Ito T; Yagi S; Seo S; Hata K; Taura K; Uemoto S
Int J Surg Case Rep; 2020; 74():46-52. PubMed ID: 32791447
[TBL] [Abstract][Full Text] [Related]
10. Living donor liver transplantation for hepatocellular carcinoma: a special reference to a preoperative des-gamma-carboxy prothrombin value.
Shimada M; Yonemura Y; Ijichi H; Harada N; Shiotani S; Ninomiya M; Terashi T; Yoshizumi T; Soejima Y; Maehara Y
Transplant Proc; 2005 Mar; 37(2):1177-9. PubMed ID: 15848661
[TBL] [Abstract][Full Text] [Related]
11. Mixed Hepatocellular Cholangiocarcinoma: A Comparison of Survival between Mixed Tumors, Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma from a Single Center.
Penzkofer L; Gröger LK; Hoppe-Lotichius M; Baumgart J; Heinrich S; Mittler J; Gerber TS; Straub BK; Weinmann A; Bartsch F; Lang H
Cancers (Basel); 2023 Jan; 15(3):. PubMed ID: 36765596
[TBL] [Abstract][Full Text] [Related]
12. Homocysteine: A novel prognostic biomarker in liver transplantation for alpha-fetoprotein- negative hepatocellular carcinoma.
Yang M; Tan W; Yang X; Zhuo J; Lin Z; Cen B; Lian Z; Li H; Lu D; Wei X; Zheng S; Xu X
Cancer Biomark; 2020; 29(2):197-206. PubMed ID: 32623388
[TBL] [Abstract][Full Text] [Related]
13. Can living donor liver transplantation offer similar outcomes to deceased donor liver transplantation using expanded selection criteria for hepatocellular carcinoma?
Chen LP; Li C; Wen TF; Yan LN; Li B; Yang JY
Pak J Med Sci; 2015; 31(4):763-9. PubMed ID: 26430399
[TBL] [Abstract][Full Text] [Related]
14. Longterm prognosis of combined hepatocellular carcinoma-cholangiocarcinoma following liver transplantation and resection.
Jung DH; Hwang S; Song GW; Ahn CS; Moon DB; Kim KH; Ha TY; Park GC; Hong SM; Kim WJ; Kang WH; Kim SH; Yu ES; Lee SG
Liver Transpl; 2017 Mar; 23(3):330-341. PubMed ID: 28027599
[TBL] [Abstract][Full Text] [Related]
15. Evaluation methods for pretransplant oncologic markers and their prognostic impacts in patient undergoing living donor liver transplantation for hepatocellular carcinoma.
Shindoh J; Sugawara Y; Nagata R; Kaneko J; Tamura S; Aoki T; Sakamoto Y; Hasegawa K; Tanaka T; Kokudo N
Transpl Int; 2014 Apr; 27(4):391-8. PubMed ID: 24472068
[TBL] [Abstract][Full Text] [Related]
16. The clinical characteristics and prognostic factors of combined Hepatocellular Carcinoma and Cholangiocarcinoma, Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma after Surgical Resection: A propensity score matching analysis.
Tang Y; Wang L; Teng F; Zhang T; Zhao Y; Chen Z
Int J Med Sci; 2021; 18(1):187-198. PubMed ID: 33390787
[No Abstract] [Full Text] [Related]
17. Impact of des-gamma-carboxy prothrombin and tumor size on the recurrence of hepatocellular carcinoma after living donor liver transplantation.
Taketomi A; Sanefuji K; Soejima Y; Yoshizumi T; Uhciyama H; Ikegami T; Harada N; Yamashita Y; Sugimachi K; Kayashima H; Iguchi T; Maehara Y
Transplantation; 2009 Feb; 87(4):531-7. PubMed ID: 19307789
[TBL] [Abstract][Full Text] [Related]
18. Living
Ogawa K; Takada Y
Transl Gastroenterol Hepatol; 2016; 1():35. PubMed ID: 28138602
[TBL] [Abstract][Full Text] [Related]
19. Living donor liver transplantation for hepatocellular carcinoma: Tokyo University series.
Sugawara Y; Tamura S; Makuuchi M
Dig Dis; 2007; 25(4):310-2. PubMed ID: 17960065
[TBL] [Abstract][Full Text] [Related]
20. [Study on the value of serum des-γ-carboxy prothrombin in predicting hepatocellular carcinoma recurrence after liver transplantation].
Xu Y; Wang PX; Cheng JW; Huang XW; Zhou J; Fan J; Yang XR
Zhonghua Gan Zang Bing Za Zhi; 2020 Nov; 28(11):918-923. PubMed ID: 33256276
[No Abstract] [Full Text] [Related]
[Next] [New Search]
